Comparison of iproniazid with other amine oxidase inhibitors, including W-1544, JB-516, RO 4-1018, and RO 5-0700.

Suppr

超能文献

作者信息

BAILEY S D, BUCCI L, GOSLINE E, KLINE N S, PARK I H, ROCHLIN D, SAUNDERS J C, VAISBERG M

出版信息

Ann N Y Acad Sci. 1959 Sep 17;80:652-68. doi: 10.1111/j.1749-6632.1959.tb49243.x.

DOI:10.1111/j.1749-6632.1959.tb49243.x

PMID:13795859

Abstract

摘要

相似文献

Comparison of iproniazid with other amine oxidase inhibitors, including W-1544, JB-516, RO 4-1018, and RO 5-0700.

Ann N Y Acad Sci. 1959 Sep 17;80:652-68. doi: 10.1111/j.1749-6632.1959.tb49243.x.

A comparative trial of four monoamine oxidase inhibitors on chronic depressives.

J Ment Sci. 1961 May;107:538-46. doi: 10.1192/bjp.107.448.538.

Chemical treatment of depression.

Ann N Y Acad Sci. 1959 Sep 17;80:734-44. doi: 10.1111/j.1749-6632.1959.tb49250.x.

Three amine-oxidase inhibitor drugs in the treatment of depression; relative value and toxic effects.

Lancet. 1961 Jan 7;1(7167):17-8. doi: 10.1016/s0140-6736(61)92185-7.

[On monoamine-oxidase inhibitors].

Psychiatr Neurol (Basel). 1960 Jul;140:92-6.

[Our experiences with monoamine oxidase inhibiting substances].

Psychiatr Neurol (Basel). 1960 Jul;140:148-51.

The use of iproniazid in the treatment of depressive states.

Ann N Y Acad Sci. 1959 Sep 17;80:745-53. doi: 10.1111/j.1749-6632.1959.tb49251.x.

Experience with JB-516 and other psychochemicals.

Ann N Y Acad Sci. 1959 Sep 17;80:835-42. doi: 10.1111/j.1749-6632.1959.tb49259.x.

The use of JB-516 in psychiatry.

Ann N Y Acad Sci. 1959 Sep 17;80:705-11. doi: 10.1111/j.1749-6632.1959.tb49247.x.

The inert psychasthenic reaction (anhedonia) as differentiated from classic depression and its response to iproniazid.

Ann N Y Acad Sci. 1959 Sep 17;80:669-79. doi: 10.1111/j.1749-6632.1959.tb49244.x.

引用本文的文献

The structure of monoamine oxidases: past, present, and future.

J Neural Transm (Vienna). 2018 Nov;125(11):1567-1579. doi: 10.1007/s00702-018-1915-z. Epub 2018 Aug 24.

Advances in the Management of Treatment-Resistant Depression.

Focus (Am Psychiatr Publ). 2010 Fall;8(4):488-500. doi: 10.1176/foc.8.4.foc488.

Deep brain stimulation for psychiatric disorders.

Annu Rev Neurosci. 2011;34:289-307. doi: 10.1146/annurev-neuro-061010-113638.

Stuck in a rut: rethinking depression and its treatment.

Trends Neurosci. 2011 Jan;34(1):1-9. doi: 10.1016/j.tins.2010.10.004. Epub 2010 Nov 8.

ALPHA-ETHYLTRYPTAMINE (ETRYPTAMINE): AN ELECTROENCEPHALOGRAPHIC, BEHAVIORAL AND NEUROCHEMICAL ANALYSIS.

Psychopharmacologia. 1963 Jul 2;4:354-66. doi: 10.1007/BF00405246.

Fatal jaundice after administration of pheniprazine.

Br Med J. 1961 Dec 16;2(5267):1616-7. doi: 10.1136/bmj.2.5267.1616.

Electroencephalographic studies on the action of monoamine oxidase inhibitor.

Psychopharmacologia. 1964 Nov 11;6(5):368-87. doi: 10.1007/BF00404246.

The negative symptoms of schizophrenia and the monoamine oxidase inhibitors.

Psychopharmacology (Berl). 1987;91(1):104-8. doi: 10.1007/BF00690936.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Comparison of iproniazid with other amine oxidase inhibitors, including W-1544, JB-516, RO 4-1018, and RO 5-0700.

Ann N Y Acad Sci. 1959 Sep 17;80:652-68. doi: 10.1111/j.1749-6632.1959.tb49243.x.

A comparative trial of four monoamine oxidase inhibitors on chronic depressives.

J Ment Sci. 1961 May;107:538-46. doi: 10.1192/bjp.107.448.538.

Chemical treatment of depression.

Ann N Y Acad Sci. 1959 Sep 17;80:734-44. doi: 10.1111/j.1749-6632.1959.tb49250.x.

Three amine-oxidase inhibitor drugs in the treatment of depression; relative value and toxic effects.

Lancet. 1961 Jan 7;1(7167):17-8. doi: 10.1016/s0140-6736(61)92185-7.

[On monoamine-oxidase inhibitors].

Psychiatr Neurol (Basel). 1960 Jul;140:92-6.

[Our experiences with monoamine oxidase inhibiting substances].

Psychiatr Neurol (Basel). 1960 Jul;140:148-51.

The use of iproniazid in the treatment of depressive states.

Ann N Y Acad Sci. 1959 Sep 17;80:745-53. doi: 10.1111/j.1749-6632.1959.tb49251.x.

Experience with JB-516 and other psychochemicals.

Ann N Y Acad Sci. 1959 Sep 17;80:835-42. doi: 10.1111/j.1749-6632.1959.tb49259.x.

The use of JB-516 in psychiatry.

Ann N Y Acad Sci. 1959 Sep 17;80:705-11. doi: 10.1111/j.1749-6632.1959.tb49247.x.

The inert psychasthenic reaction (anhedonia) as differentiated from classic depression and its response to iproniazid.

Ann N Y Acad Sci. 1959 Sep 17;80:669-79. doi: 10.1111/j.1749-6632.1959.tb49244.x.

引用本文的文献

The structure of monoamine oxidases: past, present, and future.

J Neural Transm (Vienna). 2018 Nov;125(11):1567-1579. doi: 10.1007/s00702-018-1915-z. Epub 2018 Aug 24.

Advances in the Management of Treatment-Resistant Depression.

Focus (Am Psychiatr Publ). 2010 Fall;8(4):488-500. doi: 10.1176/foc.8.4.foc488.

Deep brain stimulation for psychiatric disorders.

Annu Rev Neurosci. 2011;34:289-307. doi: 10.1146/annurev-neuro-061010-113638.

Stuck in a rut: rethinking depression and its treatment.

Trends Neurosci. 2011 Jan;34(1):1-9. doi: 10.1016/j.tins.2010.10.004. Epub 2010 Nov 8.

ALPHA-ETHYLTRYPTAMINE (ETRYPTAMINE): AN ELECTROENCEPHALOGRAPHIC, BEHAVIORAL AND NEUROCHEMICAL ANALYSIS.

Psychopharmacologia. 1963 Jul 2;4:354-66. doi: 10.1007/BF00405246.

Fatal jaundice after administration of pheniprazine.

Br Med J. 1961 Dec 16;2(5267):1616-7. doi: 10.1136/bmj.2.5267.1616.

Electroencephalographic studies on the action of monoamine oxidase inhibitor.

Psychopharmacologia. 1964 Nov 11;6(5):368-87. doi: 10.1007/BF00404246.

The negative symptoms of schizophrenia and the monoamine oxidase inhibitors.

Psychopharmacology (Berl). 1987;91(1):104-8. doi: 10.1007/BF00690936.